TY - JOUR
T1 - Inflammation Markers among Schizophrenia Patients Who Use Cannabis
AU - Fridman, Jonathan
AU - Bloemhof-Bris, Esther
AU - Weizman, Shira
AU - Kessler, Tal
AU - Porat, Dorit
AU - Ivry, Amos
AU - Wolf, Aviva
AU - Stryjer, Rafael
AU - Shelef, Assaf
N1 - Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2023/7/1
Y1 - 2023/7/1
N2 - Objectives The mechanism of inflammation of the immune system, for example, such circulatory markers as the neutrophil-to-lymphocyte ratio (NLR) and mean platelet volume (MPV), has been shown in many studies to be associated with schizophrenia. In addition, it has been shown that the cannabidiol component reduces the activation of the acquired immune system. This study examined the differences in the levels of NLR and MPV among schizophrenia patients with cannabis use versus those without. Methods In 2019 to 2020, a retrospective cross-sectional study was conducted based on digital medical records. Demographic, clinical, and complete blood cell count data were collected from records of rehospitalization of active psychotic schizophrenia inpatients. Data on NLR, MPV values, and demographic and clinical characteristics were compared between the groups and according to the degree of prevalence of cannabis use. Results No differences were found in the NLR and MPV values between the groups. Conclusion The results were contrary to our expectations. These results may be explained by the presentation of a "pseudo-balanced"picture created when multiple processes affect inflammatory indices.
AB - Objectives The mechanism of inflammation of the immune system, for example, such circulatory markers as the neutrophil-to-lymphocyte ratio (NLR) and mean platelet volume (MPV), has been shown in many studies to be associated with schizophrenia. In addition, it has been shown that the cannabidiol component reduces the activation of the acquired immune system. This study examined the differences in the levels of NLR and MPV among schizophrenia patients with cannabis use versus those without. Methods In 2019 to 2020, a retrospective cross-sectional study was conducted based on digital medical records. Demographic, clinical, and complete blood cell count data were collected from records of rehospitalization of active psychotic schizophrenia inpatients. Data on NLR, MPV values, and demographic and clinical characteristics were compared between the groups and according to the degree of prevalence of cannabis use. Results No differences were found in the NLR and MPV values between the groups. Conclusion The results were contrary to our expectations. These results may be explained by the presentation of a "pseudo-balanced"picture created when multiple processes affect inflammatory indices.
KW - MPV
KW - NLR
KW - cannabidiol
KW - cannabis
KW - inflammation markers
KW - schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=85165371305&partnerID=8YFLogxK
U2 - 10.1097/WNF.0000000000000558
DO - 10.1097/WNF.0000000000000558
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 37335845
AN - SCOPUS:85165371305
SN - 0362-5664
VL - 46
SP - 145
EP - 148
JO - Clinical Neuropharmacology
JF - Clinical Neuropharmacology
IS - 4
ER -